Modeling of enzymatic transesterification for omega-3 fatty acids enrichment in fish oil

Mathematical models of transesterification commonly assume that oil is a mixture of triacylglycerols, where each component has only one type of acid attached. This article aims to show how a different assumption on acid distribution affects the results of acylglycerols fraction composition. Experiments of fish oil ethanolysis have been performed at different enzyme loadings and ethanol concentrations, leading to enrichments from 35 % to 52 % of ω3 mass fraction in acylglycerols, by losing 12.1 % of ω3 as ethyl esters. A kinetic model is developed assuming both all acids of the same type on each acylglycerol and all acids randomly distributed on the available positions. The two different assumptions showed strong discrepancies on the acylglycerols fraction compositions predictions, demonstrating how the initial fatty acids distribution is important when an accurate description of the acylglycerols fraction is desired.

Dietary Fish Oil Concentrates Associated Health Benefits: A Recent Development of Cardiovascular Risk Reduction

Fish oil is an abundant source of omega-3 (n-3 or ω-3) polyunsaturated fatty acids (PUFAs) and contains Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA). PUFAs are very effective in preventing/ inhibiting cardiovascular incidents, particularly in individuals with high cardiovascular risk/accidents. In this review, composition, extraction of fish oil and its favorable/beneficial effects in Cardiovascular Diseases (CVDs) and molecular mechanism for its treatment/reduction have been discussed. Moreover, the application of fish oil for preventive/protective and remedial/curative properties in nutritive and health benefits has been summarized. All these aspects further search the opportunities/hope and scope with its expected opening and anticipations/ possibilities to provide additional therapeutic substitutes for the reduction of CVDs and registration of new drugs.